Related Experiment Video
Updated: Feb 24, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
VKH-Like Syndrome in a Patient on Tofacitinib
Jessica H Tran1, Hamid Hosseini1, Edmund Tsui2
1Retina Division, Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
None:
Purpose: To describe a case of suspected tofacitinib-induced Vogt-Koyanagi-Harada (VKH)-like syndrome presenting with multifocal serous retinal detachments and choroidal involvement. Methods: A single case was reviewed. Results: A 66-year-old man with a history of vitiligo and vertigo presented with acute unilateral metamorphopsia. Clinical examination and multimodal imaging demonstrated multifocal serous retinal detachments with associated choroidal infiltration in the affected eye. The patient was monitored closely and experienced rapid resolution of symptoms and imaging abnormalities after discontinuation of tofacitinib. Conclusions: This case suggests a possible drug-induced VKH-like syndrome associated with tofacitinib use. Tofacitinib may be a potential risk factor for serous retinal detachment with choroidal involvement, warranting further investigation.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Chronic Kidney Disease II: Clinical Manifestations
Hypersensitivity Reactions: Immune-Complex Reactions
The JAK-STAT Signaling Pathway
Drug toxicity: Idiosyncratic Reactions
TGF - β Signaling Pathway

